CDK12-IN-E9

CAT: 0804-HY-117203A-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-117203A-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDK12-IN-E9 is a potent and selective covalent CDK12 inhibitor and a non-covalent CDK9 inhibitor, while avoiding ABC transporter-mediated efflux. CDK12-IN-E9 has weak binding ability to CDK7/CyclinH complex with an IC50> 1 μM[1].
CAS Number
[2020052-55-3]
Product Name Alternative
(1α,1'S,4β)-AZD3293; (1α,1'S,4β)-LY3314814
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk12-in-e9.html
Purity
99.71
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
C=CC(NC1=CC=CC(NC2=CC(N3[C@H](CCO)CCCC3)=NC4=C(CC)C=NN24)=C1)=O
Molecular Formula
C24H30N6O2
Molecular Weight
434.53
References & Citations
[1]Gao Y, et al. Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors. Cell Chem Biol. 2018 Feb 15;25 (2) :135-142.e5.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK12; CDK2; CDK7; CDK9

Related Products

CatalogName
HY-112261-01CDK12-IN-3
HY-171786CDK12-IN-8
HY-139328-01CDK12-IN-5
HY-139329-01CDK12-IN-6
HY-139327CDK12-IN-4
HY-162528CDK12-IN-7
HY-112626-01CDK12-IN-2
HY-160284CDK12/13-IN-1
HY-172224PARP1/CDK12-IN-1
HY-173042CDK12/13-IN-2

Alternative Products

CatalogName
BA3785-10CDK12-IN-E9
558113-01CDK12
M13145-01CDK inhibitor E9
MBS839360-01Kinase E9 antibody
M28236-01CDK12-IN-2
M33320-01CDK12-IN-3
MBS7128797-01CDK12 Antibody
MBS5800559CDK12-IN-5
MF-0050486CDK12-IN-6
MF-0039986CDK12-IN-4

Popular Products